Get startedLog in
    Picture of HUTCHMED (China) logo

    13 — HUTCHMED (China) News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    All News

    Brief: Hutchmed China Ltd says Savannah Phase II trial shows high response rates with Savolitinib plus Tagrisso

    Picture of HUTCHMED (China) logoHUTCHMED (China)
    20/03/2025 07:42
    March 20 (Reuters) - HUTCHMED (China) Ltd 0013.HK:

HUTCHMED CHINA LTD  - HUTCHMED HIGHLIGHTS SAVOLITINIB SAVANNAH PHASE II

HUTCHMED (CHINA) LTD - SAVANNAH PHASE II TRIAL SHOWS HIGH RESPONSE RATES WITH SAVOLITINIB PLUS TAGRISSO

Source text: ID:nRST3633Ba

Further company coverage: 0013.HK

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on HUTCHMED (China)

    See all news